2023
Quantifying Blood Pressure Visit-to-Visit Variability in the Real-World Setting: A Retrospective Cohort Study
Lu Y, Linderman G, Mahajan S, Liu Y, Huang C, Khera R, Mortazavi B, Spatz E, Krumholz H. Quantifying Blood Pressure Visit-to-Visit Variability in the Real-World Setting: A Retrospective Cohort Study. Circulation Cardiovascular Quality And Outcomes 2023, 16: e009258. PMID: 36883456, DOI: 10.1161/circoutcomes.122.009258.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultBlood PressureBlood Pressure DeterminationFemaleHumansHypertensionMaleMiddle AgedRetrospective StudiesRisk FactorsConceptsRetrospective cohort studyBlood pressure valuesPatient characteristicsReal-world settingCohort studyPatient subgroupsYale New Haven Health SystemMean body mass indexSystolic blood pressure valuesBlood pressure visitHistory of hypertensionCoronary artery diseaseManagement of patientsMultivariable linear regression modelsBlood pressure readingsBody mass indexPatient-level measuresBlood pressure variationAbsolute standardized differencesNon-Hispanic whitesAntihypertensive medicationsReal-world practiceVisit variabilityArtery diseaseRegression modelsAdjustment for Social Risk Factors in a Measure of Clinician Quality Assessing Acute Admissions for Patients With Multiple Chronic Conditions
Lipska K, Altaf F, Barthel A, Spatz E, Lin Z, Herrin J, Bernheim S, Drye E. Adjustment for Social Risk Factors in a Measure of Clinician Quality Assessing Acute Admissions for Patients With Multiple Chronic Conditions. JAMA Health Forum 2023, 4: e230081. PMID: 36897581, DOI: 10.1001/jamahealthforum.2023.0081.Peer-Reviewed Original ResearchConceptsMultiple chronic conditionsSocial risk factorsMedicare-Medicaid dual eligibilityRisk factorsChronic conditionsSocioeconomic status indexMeasure scoresAcute admissionsCohort studyDual eligibilityHealthcare ResearchDual-eligible patientsRetrospective cohort studyUnplanned hospital admissionsRisk of hospitalizationArea Health Resource FileService beneficiaries 65 yearsBeneficiaries 65 yearsRisk factor adjustmentStatus indexMedicare administrative claimsHospital admissionOutcome measuresAdministrative claimsMAIN OUTCOME
2019
Traditional Chinese Medicine Use in the Treatment of Acute Heart Failure in Western Medicine Hospitals in China: Analysis From the China PEACE Retrospective Heart Failure Study
Yu Y, Spatz ES, Tan Q, Liu S, Lu Y, Masoudi FA, Schulz WL, Krumholz HM, Li J, Group T. Traditional Chinese Medicine Use in the Treatment of Acute Heart Failure in Western Medicine Hospitals in China: Analysis From the China PEACE Retrospective Heart Failure Study. Journal Of The American Heart Association 2019, 8: e012776. PMID: 31364457, PMCID: PMC6761625, DOI: 10.1161/jaha.119.012776.Peer-Reviewed Original ResearchConceptsTraditional Chinese medicineAcute heart failureHeart failureEvidence-based therapiesWestern Medicine HospitalTCM useMedicine HospitalEvidence-based therapy useTraditional Chinese medicine useChinese medicine useCoronary artery diseaseHeart Failure StudyHierarchical logistic regression modelsLogistic regression modelsSalvia miltiorrhizaRandom sampleHospital bleedingPatient's bleedingPatient characteristicsArtery diseaseTherapy useMedicine useHospital characteristicsRetrospective analysisHospital usePersistent geographic variations in availability and quality of nursing home care in the United States: 1996 to 2016
Wang Y, Zhang Q, Spatz ES, Gao Y, Eckenrode S, Johnson F, Ho SY, Hu S, Xing C, Krumholz HM. Persistent geographic variations in availability and quality of nursing home care in the United States: 1996 to 2016. BMC Geriatrics 2019, 19: 103. PMID: 30975076, PMCID: PMC6460800, DOI: 10.1186/s12877-019-1117-z.Peer-Reviewed Original ResearchApplication of the VIRGO taxonomy to differentiate acute myocardial infarction in young women
Sciria CT, Dreyer RP, D'Onofrio G, Safdar B, Krumholz HM, Spatz ES. Application of the VIRGO taxonomy to differentiate acute myocardial infarction in young women. International Journal Of Cardiology 2019, 288: 5-11. PMID: 31031078, DOI: 10.1016/j.ijcard.2019.03.054.Peer-Reviewed Original ResearchConceptsCoronary artery diseaseCardiac catheterizationYoung womenNon-obstructive coronary artery diseaseSingle-center retrospective chart reviewYoung AMI Patients (VIRGO) studyObstructive coronary artery diseaseRetrospective chart reviewAcute myocardial infarctionProportion of womenUniversal definitionIndex admissionChart reviewArtery diseaseConsecutive womenMyocardial infarctionTreatment strategiesCatheterizationMore young womenType 2Type 1Class IType 4BWomenPatient studiesSevere cardiovascular morbidity in women with hypertensive diseases during delivery hospitalization
Ackerman CM, Platner MH, Spatz ES, Illuzzi JL, Xu X, Campbell KH, Smith GN, Paidas MJ, Lipkind HS. Severe cardiovascular morbidity in women with hypertensive diseases during delivery hospitalization. American Journal Of Obstetrics And Gynecology 2019, 220: 582.e1-582.e11. PMID: 30742823, DOI: 10.1016/j.ajog.2019.02.010.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultCardiomyopathiesCardiovascular DiseasesCerebrovascular DisordersCohort StudiesEclampsiaEducational StatusElectric CountershockEthnicityFemaleHeart ArrestHeart FailureHospitalizationHumansHypertension, Pregnancy-InducedInformation Storage and RetrievalInsurance, HealthLogistic ModelsMiddle AgedMultivariate AnalysisMyocardial InfarctionNew York CityObesity, MaternalPovertyPre-EclampsiaPregnancyRetrospective StudiesSeverity of Illness IndexVentricular FibrillationYoung AdultConceptsSevere cardiovascular morbidityCardiovascular morbidityDelivery hospitalizationsHypertensive disordersSevere featuresNormotensive womenGestational hypertensionCardiovascular diseaseRetrospective cohort studyClinical risk factorsPregnancy-related deathsMultivariable logistic regressionChronic hypertensionDiligent screeningSingleton gestationsCohort studyHypertensive diseaseDiabetes mellitusMaternal deathsRisk factorsInclusion criteriaDiseases-10HospitalizationMorbidityPreeclampsia
2018
Variation in the Use of Warfarin and Direct Oral Anticoagulants in Atrial Fibrillation and Associated Cost Implications
Rodwin BA, Salami JA, Spatz ES, Valero-Elizondo J, Virani SS, Blankstein R, Blaha MJ, Nasir K, Desai NR. Variation in the Use of Warfarin and Direct Oral Anticoagulants in Atrial Fibrillation and Associated Cost Implications. The American Journal Of Medicine 2018, 132: 61-70.e1. PMID: 30290193, DOI: 10.1016/j.amjmed.2018.09.026.Peer-Reviewed Original ResearchConceptsDirect oral anticoagulantsUse of DOACsAtrial fibrillationOral anticoagulantsDiseases Ninth Edition (ICD-9) codesPocket costsProportion of patientsUse of warfarinNinth Edition codesMedical Expenditure Panel SurveyPrescription drug useTotal drug expendituresPrescription drug spendingWarfarin useAnticoagulant useNationwide cohortClinical factorsMedication useEdition codesStudy populationInternational ClassificationDrug useFibrillationClinical groupsAnticoagulantsIs self‐rated health associated with ideal cardiovascular health? The Multi‐Ethnic Study of Atherosclerosis
Osibogun O, Ogunmoroti O, Spatz ES, Burke GL, Michos ED. Is self‐rated health associated with ideal cardiovascular health? The Multi‐Ethnic Study of Atherosclerosis. Clinical Cardiology 2018, 41: 1154-1163. PMID: 29896874, PMCID: PMC6173615, DOI: 10.1002/clc.22995.Peer-Reviewed Original ResearchConceptsIdeal cardiovascular healthSelf-rated healthFavorable self-rated healthOptimal cardiovascular healthSimple 7 (LS7) metricsRace/ethnicityBetter cardiovascular healthCardiovascular healthMulti-Ethnic StudyLife's Simple 7 (LS7) metricsMorbidity/mortalityHealth-promoting behaviorsCross-sectional analysisLS7 metricsCVH scoreAdjusted ORsMean ageSRH statusChronic diseasesMultinomial logistic regressionHealth statusAge groupsLogistic regressionTotal scoreMarital statusFavorable Modifiable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs Among Cancer Patients: The 2012–2013 Medical Expenditure Panel Survey
Singh J, Valero‐Elizondo J, Salami JA, Warraich HJ, Ogunmoroti O, Spatz ES, Desai N, Rana JS, Virani SS, Blankstein R, Blaha MJ, Nasir K. Favorable Modifiable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs Among Cancer Patients: The 2012–2013 Medical Expenditure Panel Survey. Journal Of The American Heart Association 2018, 7: e007874. PMID: 29686026, PMCID: PMC6015292, DOI: 10.1161/jaha.117.007874.Peer-Reviewed Original ResearchConceptsAtherosclerotic cardiovascular diseaseAbsence of ASCVDCancer patientsMedical Expenditure PanelCRF profileRepresentative US adult populationHealthcare expendituresCardiovascular risk profileRisk factor profileBurden of cancerMean annual costAnnual healthcare expendituresMedical Expenditure Panel SurveyUS adult populationLower medical expendituresYears of ageLower healthcare costsCardiovascular managementCardiovascular diseaseHigh prevalenceRepresentative adult sampleUS adultsTwo-part econometric modelHealthcare costsEconomic burdenTraditional Chinese Medicine for Acute Myocardial Infarction in Western Medicine Hospitals in China
Spatz ES, Wang Y, Beckman AL, Wu X, Lu Y, Du X, Li J, Xu X, Davidson PM, Masoudi FA, Spertus JA, Krumholz HM, Jiang L. Traditional Chinese Medicine for Acute Myocardial Infarction in Western Medicine Hospitals in China. Circulation Cardiovascular Quality And Outcomes 2018, 11: e004190. PMID: 29848478, PMCID: PMC5882246, DOI: 10.1161/circoutcomes.117.004190.Peer-Reviewed Original ResearchConceptsAcute myocardial infarctionTraditional Chinese medicineTCM useWestern Medicine HospitalMyocardial infarctionHospital bleedingMedicine HospitalChinese medicineCardiovascular risk factorsHospital-level factorsHours of hospitalizationMultivariable hierarchical modelsQuality of careLack of evidenceChart reviewChina PatientRetrospective studySecondary hospitalsEarly managementRisk factorsIntravenous useCardiovascular diseasePatientsSignificant associationHospitalNational Trends in Nonstatin Use and Expenditures Among the US Adult Population From 2002 to 2013: Insights From Medical Expenditure Panel Survey
Salami JA, Warraich HJ, Valero‐Elizondo J, Spatz ES, Desai NR, Rana JS, Virani SS, Blankstein R, Khera A, Blaha MJ, Blumenthal RS, Katzen BT, Lloyd‐Jones D, Krumholz HM, Nasir K. National Trends in Nonstatin Use and Expenditures Among the US Adult Population From 2002 to 2013: Insights From Medical Expenditure Panel Survey. Journal Of The American Heart Association 2018, 7: e007132. PMID: 29358195, PMCID: PMC5850149, DOI: 10.1161/jaha.117.007132.Peer-Reviewed Original ResearchAdultAgedAtherosclerosisDatabases, FactualDrug CostsDrug PrescriptionsDyslipidemiasFemaleHealth Care SurveysHealth ExpendituresHealthcare DisparitiesHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic AgentsLongitudinal StudiesMaleMedically UninsuredMiddle AgedPractice Patterns, Physicians'Racial GroupsRetrospective StudiesRisk FactorsSex FactorsSocioeconomic FactorsTime FactorsTreatment OutcomeUnited States
2017
Age Differences in Hospital Mortality for Acute Myocardial Infarction: Implications for Hospital Profiling.
Dharmarajan K, McNamara RL, Wang Y, Masoudi FA, Ross JS, Spatz EE, Desai NR, de Lemos JA, Fonarow GC, Heidenreich PA, Bhatt DL, Bernheim SM, Slattery LE, Khan YM, Curtis JP. Age Differences in Hospital Mortality for Acute Myocardial Infarction: Implications for Hospital Profiling. Annals Of Internal Medicine 2017, 167: 555-564. PMID: 28973634, PMCID: PMC9359429, DOI: 10.7326/m16-2871.Peer-Reviewed Original ResearchConceptsRisk-standardized mortality ratesAcute myocardial infarctionOlder patientsYounger patientsMyocardial infarctionAge groupsHospital risk-standardized mortality ratesRetrospective cohort studyHospital mortality rankingsNational Quality ForumHospital mortalityMedian hospitalHospital outcomesCohort studyACTION RegistryAMI mortalityAmerican CollegeMedicare beneficiariesAMI hospitalizationPatientsMortality rateHospitalQuality ForumHospital ValueHospital profilingOutcomes after observation stays among older adult Medicare beneficiaries in the USA: retrospective cohort study
Dharmarajan K, Qin L, Bierlein M, Choi JES, Lin Z, Desai NR, Spatz ES, Krumholz HM, Venkatesh AK. Outcomes after observation stays among older adult Medicare beneficiaries in the USA: retrospective cohort study. The BMJ 2017, 357: j2616. PMID: 28634181, PMCID: PMC5476173, DOI: 10.1136/bmj.j2616.Peer-Reviewed Original ResearchAssociation Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012–2013 Medical Expenditures Panel Survey
Salami JA, Valero‐Elizondo J, Ogunmoroti O, Spatz ES, Rana JS, Virani SS, Blankstein R, Younus A, Arrieta A, Blaha MJ, Veledar E, Nasir K. Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012–2013 Medical Expenditures Panel Survey. Journal Of The American Heart Association 2017, 6: e004996. PMID: 28600400, PMCID: PMC5669151, DOI: 10.1161/jaha.116.004996.Peer-Reviewed Original ResearchConceptsModifiable risk factorsAtherosclerotic cardiovascular diseaseCardiovascular diseaseRisk factorsPharmaceutical expenditureMedication-related expendituresSignificant marginal increaseSurvey's complex designInadequate physical activityMedical Expenditure Panel SurveyMedical Expenditure PanelHigher healthcare spendingASCVD patientsDiabetes mellitusMost deathsPhysical activityTotal pharmaceutical expenditureAdjusted relationshipMedicationsDiseaseHealthcare spendingMellitusPatientsAssociationAdultsNational Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013: Insights From the Medical Expenditure Panel Survey
Salami JA, Warraich H, Valero-Elizondo J, Spatz ES, Desai NR, Rana JS, Virani SS, Blankstein R, Khera A, Blaha MJ, Blumenthal RS, Lloyd-Jones D, Nasir K. National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013: Insights From the Medical Expenditure Panel Survey. JAMA Cardiology 2017, 2: 56-65. PMID: 27842171, DOI: 10.1001/jamacardio.2016.4700.Peer-Reviewed Original ResearchConceptsAtherosclerotic cardiovascular diseaseStatin useAdults 40 yearsUS adult populationAdult populationMedical Expenditure Panel Survey databaseRepresentative US adult populationUS adults 40 yearsRetrospective longitudinal cohort studyHigh-intensity doseHigh-risk groupLongitudinal cohort studyMedical Expenditure Panel SurveyGeneral adult populationBrand-name statinsCohort studyStatin usersCardiovascular diseaseMedical conditionsMAIN OUTCOMEUS adultsGeneral populationStatinsOOP costsGeneric statins
2016
Economic Impact of Moderate‐Vigorous Physical Activity Among Those With and Without Established Cardiovascular Disease: 2012 Medical Expenditure Panel Survey
Valero‐Elizondo J, Salami JA, Osondu CU, Ogunmoroti O, Arrieta A, Spatz ES, Younus A, Rana JS, Virani SS, Blankstein R, Blaha MJ, Veledar E, Nasir K. Economic Impact of Moderate‐Vigorous Physical Activity Among Those With and Without Established Cardiovascular Disease: 2012 Medical Expenditure Panel Survey. Journal Of The American Heart Association 2016, 5: e003614. PMID: 27604455, PMCID: PMC5079024, DOI: 10.1161/jaha.116.003614.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedArrhythmias, CardiacCardiovascular DiseasesCase-Control StudiesCoronary Artery DiseaseDiabetes MellitusExerciseFemaleHealth ExpendituresHealth ServicesHeart FailureHumansHypercholesterolemiaHypertensionMaleMiddle AgedObesityPeripheral Arterial DiseaseRetrospective StudiesSmokingStrokeUnited StatesYoung AdultConceptsModerate-vigorous physical activityDays/weekPhysical activityHealth care expendituresTotal annual health care expendituresLower health care expendituresAnnual health care expendituresCare expendituresLower health care spendingModifiable risk factorsCardiovascular disease outcomesMedical Expenditure Panel SurveyFinal study sampleYears of ageQuality of lifeMedical Expenditure PanelLink logCVD statusHealth care spendingRisk factorsDisease outcomeStudy populationUS adultsRepresentative cohortTwo-part econometric modelFavorable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs and Resource Utilization
Valero-Elizondo J, Salami JA, Ogunmoroti O, Osondu CU, Aneni EC, Malik R, Spatz ES, Rana JS, Virani SS, Blankstein R, Blaha MJ, Veledar E, Nasir K. Favorable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs and Resource Utilization. Circulation Cardiovascular Quality And Outcomes 2016, 9: 143-153. PMID: 26941417, DOI: 10.1161/circoutcomes.115.002616.Peer-Reviewed Original ResearchConceptsMedical Expenditure Panel SurveyCardiovascular diseaseCRF profileFavorable cardiovascular risk factor profileCardiovascular risk factor profileCause healthcare resource utilizationFavorable cardiovascular risk profileHealthcare expendituresCardiovascular risk profileRisk factor statusHealthcare resource utilizationRisk factor profileBurden of morbidityClinical Modification codesOverall healthcare expendituresFinal study sampleLower medical expendituresLower healthcare costsLower health expendituresHealthcare utilizationCVD statusFactor statusStudy populationInternational ClassificationTwo-part econometric modelSex Differences in Clinical Profiles and Quality of Care Among Patients With ST‐Segment Elevation Myocardial Infarction From 2001 to 2011: Insights From the China Patient‐Centered Evaluative Assessment of Cardiac Events (PEACE)‐Retrospective Study
Du X, Spatz ES, Dreyer RP, Hu S, Wu C, Li X, Li J, Wang S, Masoudi FA, Spertus JA, Nasir K, Krumholz HM, Jiang L, Group F. Sex Differences in Clinical Profiles and Quality of Care Among Patients With ST‐Segment Elevation Myocardial Infarction From 2001 to 2011: Insights From the China Patient‐Centered Evaluative Assessment of Cardiac Events (PEACE)‐Retrospective Study. Journal Of The American Heart Association 2016, 5: e002157. PMID: 26903002, PMCID: PMC4802449, DOI: 10.1161/jaha.115.002157.Peer-Reviewed Original ResearchConceptsST-segment elevation myocardial infarctionElevation myocardial infarctionQuality of careEvidence-based therapiesMyocardial infarctionClinical profileHospitalization ratesST-segment elevation myocardial infarction presentationSex differencesMyocardial infarction presentationYounger age groupsProportion of womenMyocardial infarction hospitalizationsEarly aspirinHospital deathCardiac eventsHospital admissionMedian ageSymptom onsetChina PatientRetrospective studyAdmission timeHigh riskSex disparitiesPatients
2015
Trends in Ideal Cardiovascular Health Metrics Among Employees of a Large Healthcare Organization (from the Baptist Health South Florida Employee Study)
Ogunmoroti O, Utuama O, Spatz ES, Rouseff M, Parris D, Das S, Younus A, Guzman H, Tran T, Agatston A, Feldman T, Virani SS, Maziak W, Veledar E, Nasir K. Trends in Ideal Cardiovascular Health Metrics Among Employees of a Large Healthcare Organization (from the Baptist Health South Florida Employee Study). The American Journal Of Cardiology 2015, 117: 787-793. PMID: 26754123, DOI: 10.1016/j.amjcard.2015.11.061.Peer-Reviewed Original ResearchConceptsBody mass indexIdeal cardiovascular healthCardiovascular healthCVH metricsBlood pressureTotal cholesterolBlood glucosePhysical activityComprehensive workplace wellness programIdeal cardiovascular health metricsStudy participantsHealth risk assessmentCardiovascular health metricsCochrane-Armitage testBaptist Health SystemCohort of employeesWorkplace wellness programsLarge health care organizationOverall cohortAHA criteriaMass indexMean ageHealth fairsCardiovascular diseaseMale ratioPatterns of Use of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Among Patients With Acute Myocardial Infarction in China From 2001 to 2011: China PEACE‐Retrospective AMI Study
Liu J, Masoudi FA, Spertus JA, Wang Q, Murugiah K, Spatz ES, Li J, Li X, Ross JS, Krumholz HM, Jiang L, Group C. Patterns of Use of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Among Patients With Acute Myocardial Infarction in China From 2001 to 2011: China PEACE‐Retrospective AMI Study. Journal Of The American Heart Association 2015, 4: e001343. PMID: 25713293, PMCID: PMC4345866, DOI: 10.1161/jaha.114.001343.Peer-Reviewed Original ResearchConceptsACEI/ARB therapyAcute myocardial infarctionClass I indicationsARB therapyMyocardial infarctionMortality riskReceptor blockersAngiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor BlockersEnzyme inhibitors/angiotensin receptor blockersChina PEACE-Retrospective AMI StudyChinese AMI patientsClass IIa recommendationRates of therapyAbsence of contraindicationsAngiotensin receptor blockersHigher mortality riskCost-effective therapyIIa recommendationAMI patientsChina PatientRetrospective studyHigh riskPatterns of useChinese guidelinesPatients